Table 2 Cytogenetic risk stratification of AML patients
From: Cytogenetic profile of adult acute myeloid leukemia in Egypt: a single-center experience
Risk category | No | Percent (%) |
|---|---|---|
Favorable risk | 29 | 24.2 |
t(8;21)(q22;q22) | 9 | 7.5 |
inv(16)/t(16;16)(p13;q22) | 9 | 7.5 |
t(15;17)(q24;q21) | 11 | 9.2 |
Intermediate risk | 78 | 65 |
Normal karyotype | 68 | 56.7 |
t(9;11)(p12;q23) | 1 | 0.8 |
Trisomy 8 (+ 8) | 4 | 3.3 |
Trisomy 11 (+ 11) | 2 | 1.6 |
del(3q) | 1 | 0.8 |
der(1)t(1;6)(p36;q22) | 1 | 0.8 |
i(17)(q10) | 1 | 0.8 |
Adverse risk | 13 | 10.8 |
t(v;11q23) | 8 | 6.8 |
inv(3)/t(3;3)(q21;q26) | 2 | 1.6 |
t(9;22)(q34;q11) | 1 | 0.8 |
− 7/del(7q) | 1 | 0.8 |
Complex karyotype | 1 | 0.8 |